Exploiting the biological effect exerted by lipid nanocapsules in non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) affects approximately 25% of the global adult population and can progress to end-stage liver disease with life-threatening complications; however, no pharmacologic therapy has been approved. Drug delivery systems such as lipid nanocapsules (LNCs) are a very...

Descripción completa

Detalles Bibliográficos
Autores principales: Domingues, Inês, Michalowski, Cecilia Bohns, Marotti, Valentina, Zhang, Wunan, Van Hul, Matthias, Cani, Patrice D., Leclercq, Isabelle A., Beloqui, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Publishers 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614370/
https://www.ncbi.nlm.nih.gov/pubmed/36907563
http://dx.doi.org/10.1016/j.jconrel.2023.03.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614370/
https://www.ncbi.nlm.nih.gov/pubmed/36907563
http://dx.doi.org/10.1016/j.jconrel.2023.03.012

Ejemplares similares